{
    "title": "113_hr5790",
    "content": "The Act titled \"Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014\" introduces prize competitions for improving health outcomes and reducing federal expenditures under the Public Health Service Act. The Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014 aims to improve health outcomes and reduce Federal expenditures on health programs through prize competitions. The Director of NIH, in consultation with relevant parties, will identify 3 to 5 human diseases or health conditions for focus. The Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014 requires the identification of 3 to 5 human diseases or health conditions with significant prevention and treatment spending by the Federal Government, but low research investment compared to other similar diseases. The Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014 mandates the identification of human diseases with high prevention and treatment spending by the Federal Government but low research investment compared to similar diseases. The Director of NIH is required to design prize competitions within 12 months of the Act's enactment. The Rewarding Innovation, Savings, and Effectiveness Act of 2014 directs the Director of NIH to design prize competitions to promote innovation in addressing diseases with low research investment but high prevention and treatment spending. The Rewarding Innovation, Savings, and Effectiveness Act of 2014 directs the Director of NIH to design prize competitions to promote innovation in addressing diseases with low research investment but high prevention and treatment spending. The competitions aim to award prizes to competitors with promising innovations and best solutions. The design of the competitions must be ensured. The Rewarding Innovation, Savings, and Effectiveness Act of 2014 directs the Director of NIH to design prize competitions that ensure realistic design, unbiased selection of innovations, and open participation for all competitors. The Rewarding Innovation, Savings, and Effectiveness Act of 2014 mandates the Director of NIH to create prize competitions that are fair and inclusive, focusing on unmet needs and recent innovations. The Director must consult with various experts in the process. The Director of NIH must consult with medical, economic, budgetary, innovation, and venture capital experts, as well as heads of relevant Federal agencies, for the Health Prizes Rewarding Innovation. Additionally, the Director is required to conduct simulations within 14 months of the Act's enactment. The Director of NIH is mandated to award contracts for a simulation of prize competitions within 14 months of the Health Prizes Rewarding Innovation Act's enactment to assess effectiveness. The Director of NIH is required to award contracts for a simulation of prize competitions within 14 months of the Health Prizes Rewarding Innovation Act's enactment to assess effectiveness. Within 4 months of awarding the contracts, a report on the simulation results must be submitted to Congress. Adjustments to the design must be made within 21 months of the Act's enactment based on the simulation results. The Director of NIH will make adjustments to the design of prize competitions based on simulation results and submit a report to Congress. Private entities will implement prize competitions based on the designs developed. Private entities will implement prize competitions based on designs developed under subsection (b)(2), with competitors demonstrating effectiveness over a maximum of 5 years. The Secretary and the Commissioner of Food and Drugs may provide guidance and testing facilities to qualified competitors. The Director of NIH will conduct a total of 5 prize competitions, with a limit of 2 competitions per disease or condition. The Director will also track and report on the medical efficacy of innovations funded through these competitions. The Director of NIH will conduct 5 prize competitions, tracking the medical efficacy of funded innovations. A report on the innovations' impact on Federal expenditures will be submitted to Congress annually for 5 years. The Federal Government is prohibited from acquiring intellectual property rights. The Federal Government is prohibited from acquiring intellectual property rights developed in prize competitions without written consent. The government may negotiate licenses for the use of such intellectual property. Authorization of appropriations is required to carry out this section. Authorization of appropriations is required to carry out this section, with $50,000,000 authorized to be appropriated. Assistance awarded to private entities for prize competitions must allocate not more than 30 percent for administration. The section specifies that 70 percent of assistance for prize competitions must be awarded as prizes to competitors. Additionally, certain prizes for improving health outcomes are excluded from gross income of recipients according to the Internal Revenue Code. The amendment excludes certain prizes for improving health outcomes from gross income for taxpayers participating in prize competitions under section 409K of the Public Health Service Act. This amendment applies to taxable years ending after the enactment of the Act."
}